R. Kralovics et al., ABSENCE OF POLYCYTHEMIA IN A CHILD WITH A UNIQUE ERYTHROPOIETIN RECEPTOR MUTATION IN A FAMILY WITH AUTOSOMAL-DOMINANT PRIMARY POLYCYTHEMIA, The Journal of clinical investigation, 102(1), 1998, pp. 124-129
Primary familial and congenital polycythemia (PFCP or familial erythro
cytosis) is a rare proliferative disorder of erythroid progenitor cell
s, characterized by elevated erythrocyte mass and hemoglobin concentra
tion, hypersensitivity of erythroid progenitors to erythropoietin (EPO
), and autosomal dominant inheritance or sporadic occurrence. A number
of EPO receptor (EPOR) mutations were found in subjects with PFCP; mo
st of these mutations resulted in the truncation of the COOH-terminal
of the EPOR protein. We studied, a family with autosomal dominant inhe
ritance of PFCP in which four subjects were affected in three generati
ons. We screened the affected individuals for EPOR gene mutations usin
g SSCP analysis and found a C5964G mutation in exon VIII that changes
tyrosine codon 426 to a translation termination codon resulting in an
EPOR protein truncated by 83 amino acids, The mutant C5964G-EPOR exhib
ited hypersensitive EPO-dependent proliferation compared to the wild-t
ype EPOR when tested in a murine interleukin-3-dependent myeloid cell
line (FDC-P1), We also examined the segregation of the mutation with P
FCP in the family and found that a child in the third generation inher
ited the mutation without having laboratory evidence of polycythemia.
Further in vitro analysis of the erythroid progenitor cells of this af
fected child revealed that the progenitor cells were hypersensitive to
EPO (a hallmark of PFCP) suggesting the presence of the disease at th
e level of progenitor cells. Failure of this child to develop polycyth
emia suggests the existence of as yet unidentified environmental or ge
netic factors that map suppress disease development.